SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+1.2%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$391M
AUM Growth
+$391M
(+2.1%)
Cap. Flow
-$9.51M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
63.31%
Holding
39
New
11
Increased
9
Reduced
8
Closed
10
Top Buys
| 1 |
Viatris
VTRS
|
$25.7M |
| 2 |
AET
Aetna Inc
AET
|
$25.3M |
| 3 |
CVS Health
CVS
|
$22.9M |
| 4 |
Abbott
ABT
|
$17.5M |
| 5 |
Novartis
NVS
|
$17.2M |
Top Sells
| 1 |
Halozyme
HALO
|
$66.7M |
| 2 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$32.2M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$28.3M |
| 4 |
Elevance Health
ELV
|
$24.1M |
| 5 |
Encompass Health
EHC
|
$17M |
Sector Composition
| 1 | Healthcare | 77.76% |
| 2 | Financials | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sanofi
SNY
$121B
| $43M | 10.98% |
999,786
+202,300
| +25% | +$8.7M |
|
2
Regeneron Pharmaceuticals
REGN
$61.5B
| $42.7M | 10.89% |
113,500
+36,200
| +47% | +$13.6M |
|
|
3
Viatris
VTRS
$12.3B
| $25.7M | 6.55% |
+606,500
| New | +$25.7M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $25.3M | 6.46% |
+140,200
| New | +$25.3M |
|
|
5
CVS Health
CVS
$92.8B
| $22.9M | 5.84% |
+315,500
| New | +$22.9M |
|
6
Ironwood Pharmaceuticals
IRWD
$214M
| $21.7M | 5.54% |
1,448,800
+941,800
| +186% | +$14.1M |
|
|
7
Abbott
ABT
$231B
| $17.5M | 4.48% |
+307,400
| New | +$17.5M |
|
|
8
Novartis
NVS
$245B
| $17.2M | 4.39% |
+204,900
| New | +$17.2M |
|
|
AERI
9
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $16.6M | 4.25% |
278,400
+47,200
| +20% | +$2.82M |
|
|
AGN.PRA
10
DELISTED
Allergan plc.
AGN.PRA
| – | – |
-43,600
| Closed | -$32.2M |
|
|
ELGX
11
DELISTED
Endologix Inc
ELGX
| $11.8M | 3% |
2,196,225
+1,294,684
| +144% | +$6.93M |
|
|
CERN
12
DELISTED
Cerner Corp
CERN
| $11.4M | 2.91% |
+169,000
| New | +$11.4M |
|
13
TG Therapeutics
TGTX
$4.65B
| $11.1M | 2.84% |
1,355,178
+491,678
| +57% | +$4.03M |
|
14
Medtronic
MDT
$119B
| $11.1M | 2.84% |
137,600
+14,400
| +12% | +$1.16M |
|
|
15
Halozyme
HALO
$8.56B
| $10.9M | 2.78% |
537,500
-3,292,690
| -86% | -$66.7M |
|
16
MiMedx Group
MDXG
$1.05B
| $9.16M | 2.34% |
+726,300
| New | +$9.16M |
|
|
ALDR
17
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $9.01M | 2.3% |
786,870
+145,700
| +23% | +$1.67M |
|
18
Select Medical
SEM
$1.61B
| $8.66M | 2.21% |
+490,500
| New | +$8.66M |
|
|
RVNC
19
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.45M | 2.16% |
+236,355
| New | +$8.45M |
|
|
AGN
20
DELISTED
Allergan plc
AGN
| $8M | 2.04% |
48,900
-11,200
| -19% | -$1.83M |
|
|
CNCE
21
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $7.15M | 1.83% |
276,345
-59,100
| -18% | -$1.53M |
|
|
SIEN
22
DELISTED
Sientra, Inc.
SIEN
| $6.81M | 1.74% |
484,607
+354,200
| +272% | +$4.98M |
|
|
AVXS
23
DELISTED
AveXis, Inc. Common Stock
AVXS
| $6.43M | 1.64% |
+58,100
| New | +$6.43M |
|
|
24
Encompass Health
EHC
$12.3B
| $5.75M | 1.47% |
116,300
-343,300
| -75% | -$17M |
|
|
NXTM
25
DELISTED
NxStage Medical Inc.
NXTM
| $5.17M | 1.32% |
+213,200
| New | +$5.17M |
|